54 results on '"Olivé, A"'
Search Results
2. Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1
3. A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens
4. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis
5. The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells
6. HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells
7. A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
8. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
9. Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations
10. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome
11. PKC ζ–mTOR pathway: a new target for rituximab therapy in follicular lymphoma
12. CD molecules 2005: human cell differentiation molecules
13. 5-Azacytidine and Venetoclax Combination Boost Vγ9Vδ2 T Cell Effector Functions
14. A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility
15. Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia
16. Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses
17. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment
18. The C-class chemokine lymphotactin costimulates the apoptosis of human CD4+ T cells
19. Hydroxyurea: a new old therapy for Langerhans cell histiocytosis
20. The C-class chemokine, lymphotactin, impairs the induction of Th1-type lymphokines in human CD4+ T cells
21. Human Immunodeficiency Virus Type 1 Nef Protein Sensitizes CD4+ T Lymphoid Cells to Apoptosis via Functional Upregulation of the CD95/CD95 Ligand Pathway
22. Anti-BTN3A 20.1 Agonist Monoclonal Antibody Enhances Autologous Vγ9Vδ2 T Cells Cytotoxicity Against Primary Acute Myeloid Blasts
23. Incorporation of Thiotepa in a Reduced Intensity Conditioning Regimen Leads to Improved Engraftment after Stem Cell Transplant for Patients with Hemophagocytic Lymphohistiocytosis
24. Comprehensive Cell Specific Transcriptome Profiling of a Pediatric Hodgkin Lymphoma Cohort
25. Evaluating Anti-TNF-Alpha Therapy in Patients with Relapsed and Refractory Langerhans Cell Histiocytosis
26. Clinical Outcomes and Molecular Responses in Children with Langerhans Cell Histiocytosis Treated with MAPK Pathway Inhibitors
27. Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations
28. Immune Checkpoint Inhibitors Restore Function of Lesion Infiltrating T Lymphocytes in Langerhans Cell Histiocytosis
29. Plasma Inflammatory Protein Profiles Distinguish Hemophagocytic Lymphohistiocytosis from Sepsis and SIRS
30. Randomized Phase 2 Trial of Lirilumab (anti-KIR monoclonal antibody, mAb) As Maintenance Treatment in Elderly Patients (pts) with Acute Myeloid Leukemia (AML): Results of the Effikir Trial
31. A Systematic Approach to Providing Safe Quality Care for Patients Receiving Engineered, Non-Stem Cell Therapies
32. Follicular Lymphoma B Cells Generate Functional Regulatory T Cells Via ICOS/ICOSL Pathway and Are Inhibited By Intratumoral Tregs
33. Hydroxyurea for the Treatment of Relapsed/Refractory Langerhans Cell Histiocytosis
34. Differential Development of Donor Bone Marrow-Derived Thymocytes after Allogeneic in Utero Hematopoietic Cell Transplantation in the Murine Model
35. Vgamma9Vdelta2 T Cells-Based Immunotherapy Targeting BTN3 Molecules in Acute Myeloid Leukemia
36. Mixed Phenotype Acute Leukemia (MPAL) Has a High Frequency of Mutations in Epigenetic Regulatory Genes: Results from Whole Exome Sequencing
37. Influence of Btk Inhibitors on Antitumor Activity of Natural Killer Cells
38. Unrelated Cord Blood Transplantation for Children with Juvenile Myelomonocytic Leukemia
39. Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation
40. CD8+ /ICOS+ /CXCR5+ Tumor Infiltrating T-CELLS (CD8fc) Sharing Functional Similarities With TFH CELLS ARE Present In Classical Hodgkin'S Lymphoma Tissues Displaying A Specific “MIXED NODULARITY” Pattern
41. Defective Triggering of NK Cells Results in Primary CLL Cells Resistance to Cytotoxicity,
42. Anti-Leukemic Effect of IMiDs® in AML Involves the Direct Cytotoxicity Effects in Addition to a Biased NK Activation,
43. Natural Killer Cells Recovery After Consolidation Chemotherapy in Elderly Patients with Acute Myeloid Leukemia (AML)
44. Unrelated Cord Blood Transplantation for Children with Juvenile Myelomonocytic Leukemia.
45. Anti-Acute Myeloid Leukemia Activity of Chaetocin, a Novel Epigenetic Drug Inhibitor Inducing Oxidative Stress.
46. The Non-Death Domain Containing TNFR Member HVEM Induces Apoptosis and Chemokine Production on B-Chronic Lymphocytic Leukemia Cells.
47. Plasma Proteomic Profiles May Predict Early Acute Graft-vs.-Host Disease (aGVHD) Following Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Sibling Transplantation (allo-SCT).
48. Inflammatory Cytokines and Acute Graft-Versus-Host Disease (aGVHD) after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT).
49. Impact of Recovery of CD4 and CD8 Lymphocyte Subsets on Acute GVHD after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT).
50. High-Dose Recombinant Interleukin-2 and Acute Myeloid Leukemias in Relapse
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.